非経口栄養の世界市場レポート 2025年

非経口栄養市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.5％で92億1,000万米ドルに成長します。予測期間の成長は、高齢者人口の増加、急速な都市化と可処分所得の増加、M&Aの増加に起因すると考えられます。予測期間の主な動向としては、製品の革新、美容における人工知能の利用、焦点高周波技術の開発、レーザー支援脂肪吸引の利用、提携や共同研究などが挙げられます。

栄養失調の世界の蔓延が非経口栄養市場の成長を促進しています。栄養不良には、エネルギーや栄養素の摂取不足、過剰、不均衡が含まれます。免疫機能障害や栄養不足につながる早産の増加により、小児や乳幼児の間で非経口栄養の需要が高まっています。例えば、米国を拠点とする国連国際児童緊急基金（UNICEF）は2023年5月、5歳未満の子どもの死亡原因の約半数が栄養不足に起因すると報告しました。栄養不足は、一般的な感染症による死亡リスクを高め、感染症の頻度と重症度を高め、回復を遅らせる。そのため、世界的に栄養不良の蔓延が深刻化しており、今後数年間で非経口栄養の需要を大幅に押し上げると予測されます。

出生率の上昇は、今後数年間の非経口栄養市場の成長を促進すると予測されています。出生率とは、一般人口1,000人当たりの年間出生数です。出生率や出生率の増加は、出産適齢期の女性や新米ママの栄養不良負担の増大を示す重要な指標であり、非経口栄養の需要を押し上げます。例えば、国連が2022年7月に発表した第27回世界人口見通しによると、米国の出生率は人口1,000人当たり12.012人となり、0.09％増加しました。その結果、出生率の上昇は非経口栄養市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界非経口栄養PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の非経口栄養市場：成長率分析
• 世界の非経口栄養市場の実績：規模と成長, 2019-2024
• 世界の非経口栄養市場の予測：規模と成長, 2024-2029, 2034F
• 世界非経口栄養総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の非経口栄養市場構成別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アミノ酸
• 脂肪
• 炭水化物
• 微量元素
• ビタミン
• 鉱物
• その他の作品
• 世界の非経口栄養市場消費者タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 子供と新生児
• 大人
• 世界の非経口栄養市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• ホームケア
• その他のエンドユーザー
• 世界の非経口栄養市場アミノ酸の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 必須アミノ酸
• 非必須アミノ酸
• 特殊アミノ酸ソリューション
• 世界の非経口栄養市場、脂肪の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脂質乳剤（大豆油、オリーブ油など）
• 魚油ベースの脂質乳剤
• 中鎖脂肪酸トリグリセリド（MCT）
• 世界の非経口栄養市場、炭水化物の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• デキストロース溶液
• マルトデキストリン
• フルクトース
• 世界の非経口栄養市場微量元素の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 亜鉛
• 銅
• セレン
• マンガン
• 世界の非経口栄養市場ビタミンの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 水溶性ビタミン（ビタミンB群、ビタミンC）
• 脂溶性ビタミン（A、D、E、K）
• 世界の非経口栄養市場、鉱物の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 電解質（ナトリウム、カリウム、カルシウム、マグネシウム）
• リン
• 世界の非経口栄養市場、その他の構成のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗酸化物質
• 添加物
• 特殊栄養素

第7章 地域別・国別分析

• 世界の非経口栄養市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の非経口栄養市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 非経口栄養市場：競合情勢
• 非経口栄養市場：企業プロファイル
  • Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • ICU Medical, Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Grifols, S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Otsuka Pharmaceutical Co., Ltd.
• Claris Lifesciences Limited
• Sichuan Kelun Pharmaceutical Co., Ltd.
• JW Pharmaceuticals
• Meiji Holdings Co., Ltd.
• Aculife Healthcare Pvt. Ltd.
• Aspen Pharmacare
• Fresenius SE & Co. KGaA
• Ajinomoto Co., Inc.
• Braun Medical Inc.
• Laboratoires Aguettant
• AnazaoHealth Corporation
• Baxter Healthcare Corporation
• BioScrip, Inc.
• Sichuan Pharmaceutical Co.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 非経口栄養市場2029：新たな機会を提供する国
• 非経口栄養市場2029：新たな機会を提供するセグメント
• 非経口栄養市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Parenteral nutrition involves delivering a specific type of food intravenously, as outlined in the field of medicine. The primary goal of this therapy is to correct or prevent malnutrition. It entails administering nutrients directly into a vein. Timely achievement of a well-balanced nutritional intake is crucial for addressing complications and plays a significant role in a patient's recovery.

The key components utilized in parenteral nutrition comprise amino acids, fats, carbohydrates, trace elements, vitamins, minerals, and other elements. Amino acids-based parenteral nutrition pertains to products derived from amino acids for parenteral nutrition. Amino acids serve as a fundamental element in complete parenteral nutrition prescriptions, supporting functions such as cell, organ, skeletal, and respiratory muscle functions, as well as wound healing. These are applicable to adults, children, and newborns in various healthcare settings, including hospitals, clinics, home care, and other end-users.

The parenteral nutrition market research report is one of a series of new reports from The Business Research Company that provides parenteral nutrition market statistics, including parenteral nutrition industry global market size, regional shares, competitors with a parenteral nutrition market share, detailed parenteral nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the parenteral nutrition industry. This parenteral nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The parenteral nutrition market size has grown strongly in recent years. It will grow from $6.77 billion in 2024 to $7.16 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to rising disposable income and urbanization, a growing obese population, and the increasing popularity of noninvasive and minimally invasive aesthetic procedures.

The parenteral nutrition market size is expected to see strong growth in the next few years. It will grow to $9.21 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the increasing elderly population, rapid urbanization and rise in disposable income, and increase in mergers and acquisitions. Major trends in the forecast period include product innovations, the use of artificial intelligence in aesthetics, the development of focal radio frequency technology, the use of laser-assisted liposuction, and partnerships and collaborations.

The rising prevalence of malnutrition worldwide is propelling the growth of the parenteral nutrition market. Malnutrition encompasses deficiencies, excesses, or imbalances in a person's intake of energy or nutrients. The increase in premature births, which leads to immune dysfunction and inadequate nutrition, has heightened the demand for parenteral nutrition among children and infants. For instance, in May 2023, the United Nations International Children's Emergency Fund (UNICEF), a U.S.-based organization, reported that nearly half of all deaths in children under five can be attributed to undernutrition. Undernutrition increases the risk of death from common infections, heightens the frequency and severity of such infections, and delays recovery. Therefore, the escalating prevalence of malnutrition globally is anticipated to significantly boost the demand for parenteral nutrition in the coming years.

The rising birth rate is projected to drive the growth of the parenteral nutrition market in the coming years. The birth rate is defined as the number of live births in the general population per 1,000 people annually. An increase in birth rates and fertility rates is a significant indicator of a growing malnutrition burden among women of childbearing age and new mothers, which in turn boosts the demand for parenteral nutrition. For instance, in July 2022, the United Nations published the 27th edition of the World Population Prospects, indicating that the U.S. birth rate reached 12.012 births per 1,000 people, marking an increase of 0.09%. Consequently, the rising birth rate is expected to enhance the growth of the parenteral nutrition market.

Product innovation stands out as a prominent trend in the parenteral nutrition market. Companies in this market are introducing innovative products, such as the four-oil lipid injectable emulsion, to diversify their parenteral nutrition portfolios. For example, in March 2022, Fresenius Kabi received approval from the US FDA for SMOFlipid lipid injectable emulsion, the first and only four-oil lipid injectable emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil. This product, beneficial for its omega-3 fatty acids, is suitable for pediatric parenteral nutrition, including term and preterm neonates, in both hospital and home care settings.

Companies in the parenteral nutrition market are also concentrating on the introduction of glass packaging systems featuring innovative technologies such as SG EZ-fill packaging technology. Glass packaging systems, known for their chemical inertness and ease of sterilization, guarantee prolonged sterility while safeguarding the physical integrity of the product. In March 2022, SGD Pharma introduced ready-to-use sterile 100 ml Type 1 molded glass vials in SG EZ-fill packaging technology for aseptic fill/finish of parenteral products. The advantages of SG EZ-fill packaging technology include minimal glass-to-glass contact, reducing particle generation to ensure patient safety and minimizing the risk of contamination.

In May 2022, Fresenius Kabi, a Germany-based healthcare company specializing in lifesaving medicines and technologies, acquired Ivenix Inc. for an undisclosed amount. This strategic acquisition aims to enhance Fresenius Kabi's portfolio in the U.S. by integrating Ivenix's advanced infusion systems, thereby strengthening its offerings in the infusion therapies market. Ivenix, Inc. is a U.S.-based medical technology company focused on developing advanced infusion management systems.

Major companies operating in the parenteral nutrition market include Fresenius Kabi, Baxter International Inc., B. Braun Melsungen AG, ICU Medical, Inc., Grifols, S.A., Otsuka Pharmaceutical Co., Ltd., Claris Lifesciences Limited, Sichuan Kelun Pharmaceutical Co., Ltd., JW Pharmaceuticals, Meiji Holdings Co., Ltd., Aculife Healthcare Pvt. Ltd., Aspen Pharmacare, Fresenius SE & Co. KGaA, Ajinomoto Co., Inc., Braun Medical Inc., Laboratoires Aguettant, AnazaoHealth Corporation, Baxter Healthcare Corporation, BioScrip, Inc., Sichuan Pharmaceutical Co., United Pharmaceuticals, HOPES Pharmaceuticals, Braun Medical Ltd, Calea UK

North America was the largest region in the parenteral nutrition market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the parenteral nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the parenteral nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The parenteral nutrition market includes revenues earned by entities by infusing a specialized form of food through a vein. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Parenteral Nutrition Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on parenteral nutrition market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for parenteral nutrition ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The parenteral nutrition market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Composition: Amino Acids, Fats, Carbohydrates, Trace Elements, Vitamins, Minerals, Other Compositions
• 2) By Consumer Type: Children and New-born, Adults
• 3) By End-User: Hospitals, Clinics, Homecare, Other End Users
• Subsegments:
• 1) By Amino Acids: Essential Amino Acids; Non-Essential Amino Acids; Specialized Amino Acid Solutions
• 2) By Fats: Lipid Emulsions (Soybean Oil, Olive Oil, etc.); Fish Oil-Based Lipid Emulsions; Medium-Chain Triglycerides (MCTs)
• 3) By Carbohydrates: Dextrose Solutions; Maltodextrin; Fructose
• 4) By Trace Elements: Zinc; Copper; Selenium; Manganese
• 5) By Vitamins: Water-Soluble Vitamins (B-complex, Vitamin C); Fat-Soluble Vitamins (A, D, E, K)
• 6) By Minerals: Electrolytes (Sodium, Potassium, Calcium, Magnesium); Phosphorus
• 7) By Other Compositions: Antioxidants; Additives; Specialty Nutrients
• Companies Mentioned: Fresenius Kabi; Baxter International Inc.; B. Braun Melsungen AG; ICU Medical, Inc.; Grifols, S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Parenteral Nutrition Market Characteristics

3. Parenteral Nutrition Market Trends And Strategies

4. Parenteral Nutrition Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Parenteral Nutrition Growth Analysis And Strategic Analysis Framework

• 5.1. Global Parenteral Nutrition PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Parenteral Nutrition Market Growth Rate Analysis
• 5.4. Global Parenteral Nutrition Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Parenteral Nutrition Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Parenteral Nutrition Total Addressable Market (TAM)

6. Parenteral Nutrition Market Segmentation

• 6.1. Global Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amino Acids
• Fats
• Carbohydrates
• Trace Elements
• Vitamins
• Minerals
• Other Compositions
• 6.2. Global Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Children and New-born
• Adults
• 6.3. Global Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare
• Other End Users
• 6.4. Global Parenteral Nutrition Market, Sub-Segmentation Of Amino Acids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Essential Amino Acids
• Non-Essential Amino Acids
• Specialized Amino Acid Solutions
• 6.5. Global Parenteral Nutrition Market, Sub-Segmentation Of Fats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lipid Emulsions (Soybean Oil, Olive Oil, etc.)
• Fish Oil-Based Lipid Emulsions
• Medium-Chain Triglycerides (MCTs)
• 6.6. Global Parenteral Nutrition Market, Sub-Segmentation Of Carbohydrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dextrose Solutions
• Maltodextrin
• Fructose
• 6.7. Global Parenteral Nutrition Market, Sub-Segmentation Of Trace Elements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Zinc
• Copper
• Selenium
• Manganese
• 6.8. Global Parenteral Nutrition Market, Sub-Segmentation Of Vitamins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Water-Soluble Vitamins (B-complex, Vitamin C)
• Fat-Soluble Vitamins (A, D, E, K)
• 6.9. Global Parenteral Nutrition Market, Sub-Segmentation Of Minerals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electrolytes (Sodium, Potassium, Calcium, Magnesium)
• Phosphorus
• 6.10. Global Parenteral Nutrition Market, Sub-Segmentation Of Other Compositions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antioxidants
• Additives
• Specialty Nutrients

7. Parenteral Nutrition Market Regional And Country Analysis

• 7.1. Global Parenteral Nutrition Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Parenteral Nutrition Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Parenteral Nutrition Market

• 8.1. Asia-Pacific Parenteral Nutrition Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Parenteral Nutrition Market

• 9.1. China Parenteral Nutrition Market Overview
• 9.2. China Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Parenteral Nutrition Market

• 10.1. India Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Parenteral Nutrition Market

• 11.1. Japan Parenteral Nutrition Market Overview
• 11.2. Japan Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Parenteral Nutrition Market

• 12.1. Australia Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Parenteral Nutrition Market

• 13.1. Indonesia Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Parenteral Nutrition Market

• 14.1. South Korea Parenteral Nutrition Market Overview
• 14.2. South Korea Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Parenteral Nutrition Market

• 15.1. Western Europe Parenteral Nutrition Market Overview
• 15.2. Western Europe Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Parenteral Nutrition Market

• 16.1. UK Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Parenteral Nutrition Market

• 17.1. Germany Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Parenteral Nutrition Market

• 18.1. France Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Parenteral Nutrition Market

• 19.1. Italy Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Parenteral Nutrition Market

• 20.1. Spain Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Parenteral Nutrition Market

• 21.1. Eastern Europe Parenteral Nutrition Market Overview
• 21.2. Eastern Europe Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Parenteral Nutrition Market

• 22.1. Russia Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Parenteral Nutrition Market

• 23.1. North America Parenteral Nutrition Market Overview
• 23.2. North America Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Parenteral Nutrition Market

• 24.1. USA Parenteral Nutrition Market Overview
• 24.2. USA Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Parenteral Nutrition Market

• 25.1. Canada Parenteral Nutrition Market Overview
• 25.2. Canada Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Parenteral Nutrition Market

• 26.1. South America Parenteral Nutrition Market Overview
• 26.2. South America Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Parenteral Nutrition Market

• 27.1. Brazil Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Parenteral Nutrition Market

• 28.1. Middle East Parenteral Nutrition Market Overview
• 28.2. Middle East Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Parenteral Nutrition Market

• 29.1. Africa Parenteral Nutrition Market Overview
• 29.2. Africa Parenteral Nutrition Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Parenteral Nutrition Market, Segmentation By Consumer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Parenteral Nutrition Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Parenteral Nutrition Market Competitive Landscape And Company Profiles

• 30.1. Parenteral Nutrition Market Competitive Landscape
• 30.2. Parenteral Nutrition Market Company Profiles
  • 30.2.1. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. ICU Medical, Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Grifols, S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Parenteral Nutrition Market Other Major And Innovative Companies

• 31.1. Otsuka Pharmaceutical Co., Ltd.
• 31.2. Claris Lifesciences Limited
• 31.3. Sichuan Kelun Pharmaceutical Co., Ltd.
• 31.4. JW Pharmaceuticals
• 31.5. Meiji Holdings Co., Ltd.
• 31.6. Aculife Healthcare Pvt. Ltd.
• 31.7. Aspen Pharmacare
• 31.8. Fresenius SE & Co. KGaA
• 31.9. Ajinomoto Co., Inc.
• 31.10. Braun Medical Inc.
• 31.11. Laboratoires Aguettant
• 31.12. AnazaoHealth Corporation
• 31.13. Baxter Healthcare Corporation
• 31.14. BioScrip, Inc.
• 31.15. Sichuan Pharmaceutical Co.

32. Global Parenteral Nutrition Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Parenteral Nutrition Market

34. Recent Developments In The Parenteral Nutrition Market

35. Parenteral Nutrition Market High Potential Countries, Segments and Strategies

• 35.1 Parenteral Nutrition Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Parenteral Nutrition Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Parenteral Nutrition Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer